K
Kiniksa Pharmaceuticals Ltd D
D
KNSA
33.740
USD
0.38
(1.14%)
مغلق
حجم التداول
28,223
الربح لكل سهم
0
العائد الربحي
-
P/E
675
حجم السوق
2,500,392,718
الأخبار المقالات
العنوان: Kiniksa Pharmaceuticals International plc
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.